In 2019, a team of researchers found dairy consumption, especially of whole fat dairy, was associated with a lower risk of mortality and major cardiovascular disease events in a diverse multinational population. The study called PURE is a landmark 21-country multinational cohort study of individuals aged 35-70 years old. It tracked dietary intakes including consumption of milk, yogurt, and cheese of 138,484 individuals over time as well as mortality and total major cardiovascular events (i.e. major CVD, stroke, myocardial infarction). The researchers assessed any associations between total dairy and specific dairy product consumption with mortality and CVD events.
New data from the PURE study and published in a scientific journal in May 2020 assessing dairy intake (total, whole fat and low fat) with a prevalence of Metabolic Syndrome (MetS) and the incidence of hypertension and type 2 diabetes also found:
- Higher intake (at least two servings/day compared with zero intake) of total dairy was associated with a lower prevalence of MetS;
- Higher intake of whole fat dairy consumed alone or consumed jointly with low fat dairy was associated with a lower MetS prevalence. Low fat dairy consumed alone was not associated with MetS;
- Higher intake of total dairy was associated with a lower incidence of hypertension.
- With regards to diabetes, higher intake of both whole fat and low fat dairy was associated with a reduced risk.
The PURE study is mainly funded by the Population Health Research Institute (PHRI) as well as several government agencies and pharmaceutical companies. This specific study, Dairy consumption and cardiovascular disease in diverse populations (2018-2019), led by Andrew Mente, McMaster University, was also co-funded by Dairy Farmers of Canada (via the Nutrition Research Funding Program) and the National Dairy Council (US).